Skip to main content
SpringerLink
Log in

Palliativmedizinische Konzepte

Behandlungsmöglichkeiten bei schwerer Dyspnoe

  • Fortbildung
  • Published:
Schmerzmedizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Simon S et al. Charakteristika von Palliativpatienten mit Atemnot. Pneumologie. 2017;71(01):40-7

  2. Parshall MB et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435-52

  3. American Thoracic Society. Dyspnea: mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999;159(1):321-40

  4. Leitlinienprogramm Onkologie (Hrsg.). Deutsche Gesellschaft für Palliativmedizin. Erweiterte S3-Leitlinie Palliativmedizin für Patienten mit einer nicht-heilbaren Krebserkrankung (Stand: September 2020); https://www.awmf.org/leitlinien/detail/ll/128-001OL.html

  5. Simon ST, Bausewein C. Management of refractory breathlessness in patients with advanced cancer. Wien Med Wochenschr. 2009;159(23-24):591-98

  6. Hui D et al. Management of dyspnea in advanced cancer: ASCO Guideline. J Clin Oncol. 2021;39(12):1389-411

  7. Hui D et al. Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines. ESMO Open. 2020;5(6):e001038

  8. Currow D et al. Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial. Thorax. 2020;75(1):50-56

  9. Simon ST et al. EffenDys—Fentanyl buccal tablet for the relief of episodic breathlessness in patients with advanced cancer: a multicenter, open-label, randomized, Morphine-Controlled, crossover, phase II trial. J Pain Symptom Manage.2016;52(5):617-25

  10. Simon ST et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev. 2016;10(10):CD007354

  11. Galbraith S et al. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage. 2010;39(5):831-38

  12. Schur S et al. Sedation at the end of life - a nation-wide study in palliative care units in Austria. BMC Palliat Care. 2016;15(1):50

  13. Cherny N, ESMO Guidelines Working Group. ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation. Ann Oncol. 2014;25(suppl 3):iii143-52

  14. Clemens KE et al. Is there a higher risk of respiratory depression in opioid-naive palliative care patients during symptomatic therapy of dyspnea with strong opioids? J Pall Med. 2008;11(2):204-16

Download references

Author information

Authors and Affiliations

  1. Abteilung für Palliativmedizin, Klinische Abteilung für Innere Medizin 2, Universitätsklinikum Krems, Mitterweg 10, 3500, Krems a. d. Donau, Austria

    Gudrun Kreye

Authors
  1. Gudrun Kreye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gudrun Kreye.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kreye, G. Behandlungsmöglichkeiten bei schwerer Dyspnoe. Schmerzmed. 38, 19–21 (2022). https://doi.org/10.1007/s00940-022-3401-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00940-022-3401-9

Search

Navigation